Stereotactic Ablative Radio Therapy (SABR) followed by immunotherapy a challenge for individualized treatment of metastatic solid tumours

[1]  J. Mechalakos,et al.  Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. , 2012, International journal of radiation oncology, biology, physics.

[2]  Jedd D. Wolchok,et al.  Immunologic correlates of the abscopal effect in a patient with melanoma. , 2012, The New England journal of medicine.

[3]  Paolo A Ascierto,et al.  Combination therapy: the next opportunity and challenge of medicine , 2011, Journal of Translational Medicine.

[4]  Nicholas F. Marko,et al.  Stereotactic radiosurgical treatment of brain metastases to the choroid plexus. , 2011, International journal of radiation oncology, biology, physics.

[5]  N. Kawashima,et al.  Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 Antibody , 2009, Clinical Cancer Research.

[6]  Jan Nyman,et al.  Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  I. Lax,et al.  Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney , 2008, Acta oncologica.

[8]  L. Zitvogel,et al.  Immunogenic chemotherapy: discovery of a critical protein through proteomic analyses of tumor cells. , 2007, Cancer genomics & proteomics.

[9]  G. Wagenius,et al.  Alternating chemo-immunotherapy with temozolomide and low-dose interleukin-2 in patients with metastatic melanoma , 2006, Melanoma research.

[10]  Jan Nyman,et al.  Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries , 2006, Acta oncologica.

[11]  H. Blomgren,et al.  A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma , 2006, Acta oncologica.

[12]  Sten Nilsson,et al.  Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  N. Kawashima,et al.  Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. , 2004, International journal of radiation oncology, biology, physics.

[14]  Andrew R. Snyder.  Review of radiation-induced bystander effects , 2004, Human & experimental toxicology.

[15]  L. Zitvogel,et al.  Molecular characteristics of immunogenic cancer cell death , 2008, Cell Death and Differentiation.